"The Complexities of Resistance to Bevacizumab"
written by Anatole A. Klyosov, Igor L. Rozhanskii,
published by Journal of Cancer Therapy, Vol.3 No.5, 2012
has been cited by the following article(s)：
MP0250, a VEGF and HGF neutralizing DARPin® molecule shows high anti-tumor efficacy in mouse xenograft and patient-derived tumor models